N-Acetyl Semax 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of N-Acetyl Semax supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025087

Key analytical results include:

• Assay Content: 13.60 mg
• Identification – Retention Time: 0.990
• Identification – Spectrum: 994
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

N-Acetyl Semax is a modified peptide research compound frequently studied in controlled laboratory environments investigating neuropeptide signalling pathways and biochemical regulatory systems.

The compound belongs to a class of synthetic peptide analogues derived from Semax, a peptide studied in experimental models examining neurochemical signalling networks.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, N-Acetyl Semax has become a compound referenced in experimental neuropeptide signalling research models.

Compound Overview

N-Acetyl Semax is a synthetic derivative of the peptide Semax, structurally modified through acetylation to alter biochemical stability and interaction properties.

The compound is studied in biochemical research examining peptide-mediated signalling pathways within neural regulatory systems.

Experimental research involving N-Acetyl Semax frequently explores peptide signalling dynamics, receptor interaction systems and intracellular biochemical regulatory mechanisms.

These laboratory models allow scientists to investigate neuropeptide signalling networks and their influence on cellular communication processes.

Historical Background and Scientific Context

Scientific research into neuropeptides expanded significantly during the late twentieth century as molecular biology techniques advanced.

Researchers began developing synthetic peptide analogues designed to interact with regulatory neurochemical pathways and peptide receptor systems.

Semax emerged from this research area as a synthetic peptide analogue investigated in experimental models studying neurochemical signalling systems.

Further structural modifications such as N-Acetyl Semax have been explored in biochemical research examining peptide stability and signalling pathway interaction.

Mechanistic Focus in Research

Within experimental laboratory environments, N-Acetyl Semax is commonly studied in relation to neuropeptide signalling pathways and peptide-mediated regulatory systems.

Research investigations frequently explore the compound in experimental models examining:

• Neuropeptide signalling pathways
• Peptide-receptor interaction dynamics
• Neurochemical regulatory network modelling
• Comparative peptide analogue research
• Intracellular signalling pathway analysis
• Peptide stability and structural modification studies
• Biochemical regulatory process investigation

These experimental models allow scientists to investigate molecular signalling mechanisms involved in neuropeptide-mediated regulatory systems.

Research Applications

In controlled research environments, N-Acetyl Semax may be utilised in experimental models designed to explore neuropeptide signalling systems and biochemical regulatory pathways.

Examples of research applications include:

• Neuropeptide signalling pathway investigation
• Peptide receptor interaction studies
• Cell signalling analysis
• Comparative peptide analogue evaluation
• Neurochemical pathway modelling
• Intracellular regulatory network studies
• Controlled in vitro biochemical research

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity N-Acetyl Semax research peptide
Validated assay content 13.60 mg with purity greater than 99.8 percent
Retention time and spectral identification confirmed
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.